Clinical Trials Browser

Terminated × Interventional × MEK inhibitor I × Clear all

NCT02382549 2023-12-12

Mel61

Phase EARLY_PHASE1 Terminated

Melanoma

NCT01029418 2015-04-16

AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms